Register
Login:
Share:
Email Facebook Twitter





Add Gw Pharmaceuticals to quick picks

Gw Pharmaceuticals Share Price (GWP)



Share Price Information for Gw Pharmaceuticals (GWP)


Share Price: 510.00Bid: 509.50Ask: 510.00Change: 0.00 (0.00%)No Movement on Gw Pharm.
Spread: 0.50Spread as %: 0.10%Open: 517.50High: 519.50Low: 502.00Yesterday’s Close: 510.00
InfoGet Live Streaming Prices for GWP - Click here to start your 30 day FREE trial today.


Gw Pharmaceuticals Plc Ord 0.1P

Gw Pharmaceuticals is listed in the FTSE AIM 100, FTSE AIM UK 50, FTSE AIM All-Share
Gw Pharmaceuticals is part of the Pharmaceuticals & Biotechnology sector






Share Price SpacerPrice
510.00

Share Price SpacerBid
509.50

Share Price SpacerAsk
510.00

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
210,141

Share Price SpacerOpen
517.50

Share Price SpacerHigh
519.50

Share Price SpacerLow
502.00

Share Price SpacerClose
510.00

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 237.16m £1,209.50m 5,000

52 Week High 580.00 52 Week High Date 18-MAR-2015
52 Week Low 205.00 52 Week Low Date 16-APR-2014

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
504 83,846 126,236 -72.857 -7.00 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

01-Apr-15
17:12:24
507.2986
3,875
Sell* 
509.50
510.00
19.66k
Trade Type:
Ordinary
Bargain conditions apply

01-Apr-15
16:35:11
508.7572
9,900
Sell* 
509.50
510.00
50.37k
Trade Type:
Ordinary
Bargain conditions apply

01-Apr-15
17:02:32
510.00
1,337
Buy* 
509.50
510.00
6,819
Trade Type:
Ordinary


*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Gw Pharmaceuticals trades >>

Directors Deals for Gw Pharmaceuticals (GWP)
Trade DateActionNotifierPriceCurrencyAmountHolding
09-Feb-15Sell
Trade Notifier Information for GW Pharmaceuticals
Christopher John Tovey held the position of Chief Operating Officer at GW Pharmaceuticals at the time of this trade.
 Christopher John Tovey
404.2GBX10,0002500
09-Feb-15Sell
Trade Notifier Information for GW Pharmaceuticals
Christopher John Tovey held the position of Chief Operating Officer at GW Pharmaceuticals at the time of this trade.
 Christopher John Tovey
404.2GBX10,0002500
17-Dec-14Notification of Holding
Trade Notifier Information for GW Pharmaceuticals
Justin Gover held the position of CEO at GW Pharmaceuticals at the time of this trade.
 Justin Gover
002143315
View more Gw Pharmaceuticals directors dealings >>

Date/Time
Author
Subject
Share Price
Opinion
Wed 22:05
kingskin
RE: Medical marijuana goes federal
510.00
No Opinion

gaining ground, if / when it goes through and cannabis is rescheduled then it will of course officially have medical uses by very definition of the scheduling, which means - if i have to spell it out.......it can no longer be called ..................sssssssssssssssssssssnnnnnnnnnnake oil, even by the most stubborn of people. :) happy days.
Wed 10:20
drshaggy
RE: Medical marijuana goes federal
510.00
No Opinion

Update: http://freebeacon.com/issues/marijuana-bill-gains-cosponsors-in-house-and-senate/
Wed 09:48
FlowerPowerBob
first Phase 3 pivotal
513.50
No Opinion

http://www.briefing.com/Investor/PopupPages/ArticlePopup.aspx?ArticleId=IN20150331070151GWPH
Fri 08:15
kingskin
RE: Epidiolex trials for Idaho?
485.25
No Opinion

no, i was right, you have just proved it by basing your belief on scant information, GW was formed on the back of anecdotal tales, not clinical placebo controlled trials. sativex was developed due to anecdotal tales, epilodex was developed due to anecdotal tales, this share price is base on anecdotal tales and pretty disappointing clinical info. the efficacy of sativex is so underwhelming NICE decided to exclude it from the NHS,placebos were deemed more effective than sativex in preliminary cancer pain trials, epilodex and CW have varied results, though promising there is clearly more work to do to find out why they only work with some patients, studies are now underway in colorado to see if genetics hold the answer. we form our beliefs based on info, then look to justify those beliefs, its human nature. your claim that anything without placebo controlled data is snake oil is just the standard short-sighted approach stated by the powers that be, true pioneers look outside that box for exciting discoveries, it how and why GW was created. according to the best we have in the UK ashya king should of been blasted indiscriminately by gamma rays then poisoned with chemo, this was the only solution. in other countries this was deemed not to be the case by docs with extensive knowledge of different techniques. ashya is now reputedly cured and getting better, and hopes to live a long productive life, this would not be the case had he stayed in the UK and our nhs system. it has now been reported that the UK has a very poor standard of cancer care, we are decades behind europe and america. sometimes the so called best in the country do not have all the info, and clearly are protecting the staus quo rather than looking outside the box to truly help patients. the kings were right to do what they did, the same is true for the cannabis refugees in colorado. why shoud they wait for their child to die when CBD oils have helped so many live a normal life? its worth a try.. snake oil - https://www.youtube.com/watch?v=EUihClfzzME CW - https://www.youtube.com/watch?v=ciQ4ErmhO7g
Fri 08:05
bigbob0228
up grade
491.00
Strong Buy

http://www.themarketsdaily.com/stock-update-gw-pharmaceuticals-plc-nasdaqgwph/6626/
26 Mar '15
FlowerPowerBob
RE: Epidiolex trials for Idaho?
491.00
No Opinion

OK I was right http://www.insysrx.com/?page_id=270&link=http://insysrx.mwnewsroom.com/press-releases/insys-therapeutics-announces-its-pharmaceutical-cannabidiol-received-fast-track--nasdaq-insy-1177800?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Insys Therapeutics have got a pure CBD product now competing head on with GW for dravets syndrome. So this will be going through the same clinical trials as GW's. As CW / Snake all also contains THC then this is different to the pure CBD drugs and needs clinical tests if its to be compared to pure CBD.

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Gw Pharmaceuticals (GWP) >>
Please Login or Register to post messages



Gw Pharmaceuticals Plc Ord 0.1P home pageWebsite: Gw Pharmaceuticals Plc Ord 0.1P
Website Description: GW Pharmaceutical



Sign up for Live Prices


CD02WL.001.081313


Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.